Viewing Study NCT02332902


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-02-26 @ 3:15 AM
Study NCT ID: NCT02332902
Status: COMPLETED
Last Update Posted: 2023-12-20
First Post: 2014-12-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T
Sponsor: The University of Texas Health Science Center, Houston
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neurofibromatosis 1 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neurofibroma View
None NF-1 View
None Everolimus View
None mTOR inhibitor View